SRSF6
Serine/arginine-rich splicing factor 6
Also known as: B52, SFRS6, SRP55, SRSF6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13247
- Gene
- SRSF6
- Ensembl
- ENSG00000124193
- Chromosome
- 20
- Canonical length
- 344 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear speckles
OverviewNCBI Gene
The protein encoded by this gene is involved in mRNA splicing and may play a role in the determination of alternative splicing. The encoded nuclear protein belongs to the splicing factor SR family and has been shown to bind with and modulate another member of the family, SFRS12. Alternative splicing results in multiple transcript variants. In addition, two pseudogenes, one on chromosome 17 and the other on the X chromosome, have been found for this gene.[provided by RefSeq, Sep 2010]
Canonical amino-acid sequenceUniProt
344 residues, UniProt reviewed canonical sequence.
>Q13247|SRSF6
1 MPRVYIGRLS YNVREKDIQR FFSGYGRLLE VDLKNGYGFV EFEDSRDADD AVYELNGKEL
61 CGERVIVEHA RGPRRDRDGY SYGSRSGGGG YSSRRTSGRD KYGPPVRTEY RLIVENLSSR
121 CSWQDLKDFM RQAGEVTYAD AHKERTNEGV IEFRSYSDMK RALDKLDGTE INGRNIRLIE
181 DKPRTSHRRS YSGSRSRSRS RRRSRSRSRR SSRSRSRSIS KSRSRSRSRS KGRSRSRSKG
241 RKSRSKSKSK PKSDRGSHSH SRSRSKDEYE KSRSRSRSRS PKENGKGDIK SKSRSRSQSR
301 SNSPLPVPPS KARSVSPPPK RATSRSRSRS RSKSRSRSRS SSRDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SRSF6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 109 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 109 nTPM
- pancreas: 67 nTPM
- epididymis: 56 nTPM
- ovary: 56 nTPM
- spleen: 55 nTPM
- adrenal gland: 55 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 130 nCPM
- oligodendrocytes: 103 nCPM
- bergmann glia: 90 nCPM
- astrocytes: 81 nCPM
- choroid plexus epithelial cells: 81 nCPM
- microglia: 62 nCPM
Immune cell
- intermediate monocyte: 33 nTPM
- non-classical monocyte: 30 nTPM
- naive CD4 T-cell: 27 nTPM
- basophil: 26 nTPM
- naive CD8 T-cell: 26 nTPM
- myeloid DC: 25 nTPM
Brain region
- choroid plexus: 78 nTPM
- white matter: 63 nTPM
- cerebellum: 53 nTPM
- hypothalamus: 50 nTPM
- cerebral cortex: 49 nTPM
- basal ganglia: 44 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.37
- gnomAD pLI
- 0.91
- gnomAD missense Z
- 1.1
- DepMap mean gene effect
- -0.53
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- alternative mRNA splicing, via spliceosome
- mRNA splice site recognition
- negative regulation of keratinocyte differentiation
- negative regulation of mRNA splicing, via spliceosome
- negative regulation of type B pancreatic cell apoptotic process
- positive regulation of epithelial cell proliferation involved in lung morphogenesis
- regulation of alternative mRNA splicing, via spliceosome
- regulation of keratinocyte proliferation
- regulation of wound healing
- response to insulin
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SRSF6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SRSF6 as an antibody target. Whether an autoantibody or antibody against SRSF6 could matter depends on whether native SRSF6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SRSF6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SRSF6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...